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The regenerative capacity of injured adult central nervous system (CNS) tissue is very limited. Speciﬁcally,
traumatic spinal cord injury (SCI) leads to permanent loss of motor and sensory functions below the site of
injury, as well as other detrimental complications. A potential regenerative strategy is stem cell trans-
plantation; however, cell survival is typically less than 1%. To improve cell survival, stem cells can be
delivered in a biomaterialmatrix that provides an environment conducive to survival after transplantation.
Onemajor challenge in this approach is to deﬁne the biomaterial and cell strategies in vitro. To this end, we
investigatedboth peptide-modiﬁcation of gellan gumand olfactory ensheathing glia (OEG) on neural stem/
progenitor cell (NSPC) fate. To enhance cell adhesion, the gellan gum (GG) wasmodiﬁed using DielseAlder
click chemistry with a ﬁbronectin-derived synthetic peptide (GRGDS). Amino acid analysis demonstrated
that approximately 300nmol of GRGDSwas immobilized to eachmgofGG. TheGGeGRGDShad a profound
effect on NSPC morphology and proliferation, distinct from that of NSPCs in GG alone, demonstrating the
importance of GRGDS for cell-GG interaction. To further enhance NSPC survival and outgrowth, they were
cultured with OEG. Here NSPCs interacted extensively with OEG, demonstrating signiﬁcantly greater
survival and proliferation relative to monocultures of NSPCs. These results suggest that this co-culture
strategy of NSPCs with OEG may have therapeutic beneﬁt for SCI repair.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Traumatic spinal cord injury (SCI) usually leads to signiﬁcant
neurological deﬁcits and disabilities that result in loss of sensory
and motor function, termed paraplegia or tetraplegia depending on
the site of injury. This can subsequently result in other related
problems such as infections of the bladder and kidneys and
dysfunction of the bowel, as well as heart and respiratory system.
All of these problems have a negative effect on the physiological,
psychological and social behavior of SCI patients. Current clinicalnnelly Centre for Cellular &
, Toronto, Ontario M5S 3E1,
Shoichet).
All rights reserved.approaches are limited and mainly based on the use of anti-
inﬂammatory agents, such as methylprednisolone [1]; however,
its use is controversial as recent studies failed to reveal conclusive
beneﬁcial outcomes [2]. Some of the other strategies that have been
tested clinically include: minocycline [3], anti-NogoA [4] and
transplantation of oligodendrocyte precursor cells [5]. The latter
trial was recently canceled, underlying the urgent need to develop
therapeutic strategies that can promote regeneration after SCI.
One approach currently under investigation for regeneration
followingSCI is thetransplantationofcells into thespinalcord.Several
groups have reported that the injection of cells, such as olfactory
ensheathing glia cells (OEG or OECs) [6,7], neural stem/progenitor
cells (NSPCs) [8] or mesenchymal stem cells [9,10], leads to motor
improvements and/or tissue repair in SCI animal models. OEG are
compelling because they support and guide olfactory axons [11], are
able to grow through the glial scar [12] and secrete several
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tional repair, taking advantage of their ability to differentiate to
neurons, oligodendrocytes and astrocytes [14]. However, to date no
single repair strategyhas successfully induced full functional recovery
following SCI. Extensive cell death of the transplanted cells after
injection, due to inﬂammation and/or the absence of matrix support
[15,16], has limited the therapeutic beneﬁt. To enhance cell survival,
we investigated the co-delivery of two cell types in an engineered
matrix where the second cell type provides trophic support and the
matrix contributes to overcoming cell death through anoikis [17].
Biomaterials have been designed as vehicles for cell trans-
plantation in order to enhance cell survival after transplantation.
Hydrogels are particularly appealing for soft tissue applications
because they can be designed to match the mechanical properties
and water content of these tissues. For example, delivering NSPCs
in chitosan tubular scaffolds demonstrated NSPC survival and
promising results for tissue and functional repair [8]. The gellan
gum hydrogel is compelling because it can be injected in a mini-
mally-invasive way to form a gel in situ. Gellan gum (GG) is
a linear anionic microbial polysaccharide composed of repeating
units of glucose, glucuronic acid and rhamnose [18] and thus has
multiple hydroxyl groups available for chemical modiﬁcation. It has
been studied for drug delivery and cartilage regeneration [19e21]
and is approved by the FDA as a food additive.
In order to better mimic the extracellular matrix (ECM), bioma-
terials have been modiﬁed with several peptide sequences [22e24]
to inﬂuence biological processes, such as cell adhesion, growth and
development [25,26]. Cells transplanted in a material that mimics
both the mechanical and chemical properties of native tissue have
been shown to be more efﬁcacious after transplantation [27,28].
Here we aim to synthesize GG with enhanced cell-ECM and
cellecell interactions for ultimate use in cell transplantation. To
promote cell survival and interaction with gellan gum, we chemi-
cally conjugated the ﬁbronectin-derived peptide sequence GRGDS
via DielseAlder click chemistry and studied the impact of GRGDS-
modiﬁed gellan gum (GGeGRGDS) on cell fate. To enhance cell
survival beyond that provided by the ECM-mimetic peptide
sequence, cellecell interactions are investigated. Since OEG have
been shown to provide guidance pathways to axons and NSPCs
have been shown to promote some functional recovery, we inves-
tigated the co-culture of these two cell types to determine whether
OEG affected NSPC survival and/or differentiation. To gain a greater
appreciation of the OEGeNSPC interaction, the two cell types were
cultured in direct contact, in a transwell system or in the
GGeGRGDS. Importantly, both OEG and NSPCs can be isolated from
human patients [29,30], which enhance the eventual feasibility of
this therapeutic strategy for SCI.
2. Materials and methods
2.1. Synthesis of furan-modiﬁed gellan gum hydrogel
Gellan gum (Sigma, USA) was ﬁrst dissolved in 2-(N-morpholino)ethanesulfonic
acid (MES) buffer (100 mM, pH 5.5) at 37 C. 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (DMT-MM, Sigma, USA) and furfurylamine (Acros
Organics, Belgium) were then added in a 4:1 M ratio (of each reagent relative to the
eCOOH groups in gellan gum) and stirred at 37 C for 48 h. The solution was then
dialyzed (Mw cutoff 12e14 kDa, Spectrum Labs, USA) alternately against distilled
water and PBS (0.1 M, pH 7.2) for 5 days. Finally, water was removed by lyophilization
to obtain furan-modiﬁed gellan gum (furaneGG) as awhite powder. 1H NMR spectra
were used to analyze the degree of furan substitution. 1H NMR was recorded in D2O
on a Varian Mercury-400MHz NMR spectrometer (Palo Alto, USA). As a negative
control, GG was incubated with furfurylamine in the absence of DMT-MM.
2.2. Synthesis of maleimide-modiﬁed GRGDS peptide
Maleimide-modiﬁed GRGDS (mal-GRGDS) peptide was prepared by linear solid-
phase synthesis (SPS) using standard Fmoc chemistry [31]. Fmoc-serine Wang resin(Anaspec, USA) with a loading capacity of 0.48 mmol/g was swollen in DMF (Sigma,
USA) for 30 min. The solution was then drained and a solution of 20% piperidine
(Caledon, Canada) in DMF was added and mixed for 30 min. The resin was then
washed with DMF and tested for free amines using 1% trinitrobenzenesulfonate,
TNBS (TCI America, USA), in DMF. The ﬁrst amino acidbuilding block
(FmoceAspeOH, 3.0 equivalents, NovaBiochem) was pre-mixed with 2-(6-chloro-
1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexaﬂuorophosphate, HCTU
(3.0 equivalents, Anaspec, USA) in DMF for 15 min, then transferred to the SPS ﬂask.
1.0 M diisopropylethylamine, (DIPEA, 4.0 equivalents, Sigma, USA) in DMF was then
added and the ﬂask was stirred until the coupling reactionwas complete, which was
determined by the TNBS test (negative test outcome). The Fmoc deprotection and
coupling steps were repeated until ﬁve amino acid residues (GRGDS) were coupled
to the resin. To conjugate the maleimide linker to the deprotected N-terminus of the
peptide, 4 equivalents of maleimidopropionic acid (TCI America, USA) and 12
equivalents of diisopropylcarbodiimide (Sigma, USA) were pre-mixed in dichloro-
methane for 45 min and then added to the SPS ﬂask and stirred for 24 h. The
maleimide-modiﬁed GRGDS (mal-GRGDS) sequence was then cleaved from the
resin using 95% triﬂuoroacetic acid (Caledon, Canada) in water. The peptide was
allowed to precipitate in cold diethyl ether for 30 min. Then, the precipitate was
recovered by centrifugation. Finally, the product was puriﬁed by HPLC (Shimadzu,
Japan) in a C18, 250  10 mm, 5 um, 100 Å column. A mobile phase gradient from 5%
to 20% (Acetonitrile (with 0.1% TFA):ddH2O (with 0.1% TFA)) over 30 min was per-
formed. A 90% yield was obtained and the product was conﬁrmed by 1H NMR and
mass spectrometry (MS).
2.3. Immobilization of mal-GRGDS peptide on furaneGG hydrogel by DielseAlder
chemistry
Immobilization of maleimide-containing GRGDS (mal-GRGDS) to furan-
modiﬁed gellan gum was performed via DielseAlder chemistry between the mal-
eimide functional group of the peptide with the furan group of the gellan gum.
FuraneGG was ﬁrst dissolved in MES buffer (100 mM, pH 5.5) at 37 C (4 mg/ml).
Mal-GRGDS was then added in a 5:1 maleimide:furan molar ratio and vigorously
stirred for 48 h. The solution was then dialyzed (Mw cutoff 12e14 kDa) alternately
against distilled water and PBS (0.1 M, pH 7.2) for 5 days. Finally, the water was
removed by lyophilization to obtain GRGDS-modiﬁed Gellan Gum (GGeGRGDS) as
awhite powder. The amount of peptide immobilized on the hydrogel was calculated
by amino acid analysis. In brief, this method involved acid hydrolysis of the peptide
with 6 N HCl for 24 h, followed by derivatization with phenylisothiocyanate (PITC).
The derivatized hydrolyzates were then quantiﬁed using reverse phase HPLC. As
a negative control, mal-GRGDS was incubated with unmodiﬁed gellam gum.
2.4. Cell isolation and culture
All animal work was carried out in accordance with the Guide to the Care and
Use of Experimental Animals (Canadian Council on Animal Care) and approved by
the Animal Care Committee at the University of Toronto. Neural stem/progenitors
cells were isolated from the subependymal region of the lateral ventricles in the
forebrain of 6e8 weeks old male Wistar rats as previously described [32]. Cells were
grown in neurobasal medium (Invitrogen, Canada), with 2% of B27 neural supple-
ment (Invitrogen), 1% of L-glutamine (Sigma), 1% of penicillinestreptomycin (Sigma),
20 ng/ml EGF (recombinant human EGF; Invitrogen), 20 ng/ml bFGF (recombinant
human bFGF; Invitrogen) and 2 ng/ml heparin (Sigma). Cell number and viability
were determined with a hemocytometer using the trypan blue exclusion test.
Dissociated cells were plated in complete media and incubated in a humidiﬁed
atmosphere at 37 C with 5% of CO2. Neurospheres were observed within 1e2
weeks, after which cells were passaged weekly.
Olfactory ensheathing cells were isolated from adult male Wistar rats as
previously described [33]. Brieﬂy, upon the olfactory bulb dissection all meninges
were removed and the tissuewas digestedwith 0.125% collagenase type I (Sigma) for
20min at 37 C. The digested tissue was mechanically dissociated with a pipette and
then ﬁltered through a 40 mm cell strainer (BD Falcon, USA). After centrifugation at
1000 rpm for 10 min, cells were resuspended and plated in uncoated plates for 18 h.
A posterior change to new uncoated plates for 36 h was made, as it is expected that
most of the ﬁbroblasts and astrocytes will attach in the ﬁrst and second period,
respectively. Finally, the cell suspensions were transferred to ﬁbronectin treated
ﬂasks (coated overnight with 1 mg/ml ﬁbronectin solution, (Sigma, USA) and
cultured in DMEM/F12 (Gibco) with 10% of FBS (Gibco) and 1% of
antibioticeantimycotic solution (Sigma) at 37 C and 5% CO2. OEG were enriched by
the supplementation with Bovine Pituitary Extract (5 mg/ml, Gibco) and Forskolin
(2 mg/ml, Sigma).
2.5. Neural stem/progenitors cell culture on GRGDS-modiﬁed gellan gum
Bioactivity of GGeGRGDS was assessed by the analysis of NSPC growth,
morphology and differentiation when cultured on the hydrogel for 2 and 7 days.
NSPCs were mechanically dissociated into a single cell suspension and either seeded
on the surface or encapsulated into GGeGRGDS hydrogel in complete medium (as
described in Section 2.1). The cell density was 2  104 cells/cm2 and hydrogels were
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was used as a control. Cell growth and morphology was evaluated by phalloidin/
DAPI staining and differentiation was evaluated using immunocytochemistry (ICC).
Analysis was carried out using a Zeiss Observer Z1 microscope with a Yokogawa
confocal scan unit; images were captured and processed using Volocity 4.3.2
software.
2.6. Co-cultures between OEG and NSPCs
To evaluate the potential synergistic or antagonistic effects between OEG and
NSPCs, direct and transwell co-culture experiments were performed. OEG
(1  105 cells/cm2) and NSPCs (4  104 cells/cm2), obtained as described in section
2.4, were seeded either simultaneously onto the same ﬁbronectin-coated cover
glass, or in indirect contact by using a transwell (with OEG cultured on the
ﬁbronectin-coated cover glass and NSPCs on the transwell). Cells were allowed to
grow in complete NSPC culture medium (see section 2.4) for 24 h and then cultured
in the absence of the growth factors, FGF2 and EGF. In the direct co-culture exper-
iment, in order to clearly identify one cell population from another, OEG were
labeled (according to manufacturer instructions) with a cell tracing reagent
(C34554, Invitrogen) before seeding. After 7 days of incubation, cell growth and
NSPC differentiationwas assessed by ICC. Analysis was performed using an Olympus
BX61ﬂuorescence microscope. OEG and NSPCs cultured alone were used as controls.
After these initial experiments, OEG and NSPCswere then encapsulated together
in the GGeGRGDS hydrogel. Both cells were pre-labeled before encapsulation. A
green tracer was used for OEG labeling (C34554, Invitrogen) and NSPCs were labeled
with a far red tracer (C34553, Invitrogen). Both labeling protocols were performed
according to the manufacturer instructions. Cell interactions and growth were then
analyzed by confocal analyses after 7 days of culture.
2.7. Immunocytochemistry and phalloidin/DAPI staining
The following primary antibodies were used for the immunocytochemical
studies: monoclonal rabbit anti-b-III tubulin (1:500, Chemicon, Canada) for
neurons; monoclonal mouse anti-GFAP (1:100, Chemicon) for astrocytes; mono-
clonal mouse anti-O4 (1:200, R&D Systems, Canada) for oligodendrocytes; mono-
clonal mouse anti-Nestin (1:100, Millipore, USA) for progenitor cells; and polyclonal
rabbit anti-p75 (1:100, Millipore) for OEG. For all immunocytochemical procedures,
the appropriate controls were obtained by omission of the relevant primary anti-
body. Cells on the substrates were ﬁxed with PBS solution containing 4% para-
formaldehyde PFA for 20min (on glass) or 1 h (in the hydrogel) at room temperature
and thenwashed with PBS. Next, cell membrane permeation (except for p75 and O4
antibodies) and blocking by treating cells with 0.3% TritonX-100 (Sigma, USA) and
10% of FBS solution at room temperature for 1 h, each speciﬁc primary antibody
solution was added for 1 h (on glass) or 12 h (on hydrogel). After washing with 0.5%
of FBS in PBS, the samples were exposed to the speciﬁc secondary antibody (1:500
dilution of Alexa Fluor 488 anti-rabbit and 1:500 dilution of Alexa Fluor 594
anti-mouse, Invitrogen) for 1 h (on glass) or 5 h (on hydrogel) and then washed
with 0.5% FBS. Finally, cell nuclei were counterstained with 1 mg/ml DAPI
(Invitrogen) for 1 h.
For phalloidin/DAPI staining, cells were ﬁxed with 4% of PFA for 30 min at room
temperature and then treated with 0.3% TritonX-100. After washing several times
with PBS, 0.1 mg/ml of phalloidin (Sigma) was added to the cells for 30 min. Finally,
cell nuclei were counterstained with DAPI (1 mg/ml, Invitrogen) for 10 min.
2.8. Statistical analysis
All statistical analyses were performed using GraphPad Prism version 5.00 for
Windows (GraphPad Software, USA). Differences among groups were assessed by
two-way ANOVA followed by a Bonferroni post-hoc test (proliferation and differ-
entiation analyses of NSPCs) and by t-student test (proliferation analyses of NSPCs
and OEG in the co-cultures experiments). A p-value of 0.05 (95% conﬁdence level)
was set as the criteria for statistical signiﬁcance. All data are presented as
mean  standard deviation.
3. Results
3.1. Synthesis and characterization of GGeGRGDS hydrogel
Immobilization of the synthetic peptide (mal-GRGDS) to the
gellan gum (GG) hydrogel was achieved in two synthetic steps
(Fig. 1A). First, the carboxylic acid groups of the glucuronic acid
monosaccharide of GG were activated with DMT-MM, and then
conjugated to furfurylamine to functionalize the GG with a furan.
By 1H NMR analysis, the degree of furan substitution to GG was
calculated to be 27% (Fig. 1B). This was calculated by comparing the
ratio of the areas under the furan peaks at 6.26, 6.46 and 7.65 ppmto the methyl peak at 1.2 ppm (of the rhamnose monosaccharide of
GG). To conﬁrm that the furfurylaminewas covalently bound to GG,
and not simply adsorbed, a control reaction (in the absence of the
coupling agent, DMT-MM)was similarly characterized, and analysis
of this 1H NMR spectrum did not show any furan peaks (Fig. 1C).
Second, the furaneGG hydrogel was reacted with maleimide-
modiﬁed GRGDS peptide to yield GGeGRGDS hydrogel. After
excessive dialysis to remove unbound peptide, quantiﬁcation by
amino acid analysis of the immobilized peptide was calculated to
be 304.0 nmol of GRGDS peptide per mg of GG (Fig. 1D). A control
reaction (using unmodiﬁed GG) was also performed to determine
the amount of unbound peptide adsorbed on the hydrogel. In the
absence of furan substitution to GG, only 5.3 nmol of GRGDS/mg of
GG (Fig. 1E) was detected. Thus, approximately 300 nmol/mg of
GRGDS peptide was covalently bound to the GG by the DielseAlder
[4 þ 2] cycloaddition.
3.2. Biological effect of GGeGRGDS on NSPCs
NSPCs were either seeded on the surface or encapsulated within
GGeGRGDS and compared to NSPCs cultured with unmodiﬁed GG
hydrogels. Cell proliferation, morphology and differentiation were
assessed after 2 and 7 days of culture. The results revealed
pronounced differences in NSPC behavior when cultured in the
peptide-modiﬁed hydrogel relative to the unmodiﬁed hydrogel. In
the presence of immobilized GRGDS, the cells were able to migrate
and successfully expand throughout the hydrogel whereas in the
absence of GRGDS, NSPCs interacted preferentially with each other,
forming cell aggregates or neurospheres (Fig. 2). Visible cyto-
plasmatic extensions were observed in the GGeGRGDS, both on the
surface (Fig. 2A) and inside the gel (Fig. 2B), but not in the
unmodiﬁed GG. Moreover, proliferation (number of singles cells
between days 2 and 7) and morphological analyses revealed that in
the absence of peptides, the cells were only able to proliferate as
neurospheres whereas in the GGeGRGDS hydrogel, cells prolifer-
ated as single cells. This observation reﬂects the interaction of
NSPCs with GRGDS peptides and their lack of interaction with the
GG hydrogel. To quantify this observation, the number of single
cells found either encapsulated within or on the gel surface was
quantiﬁed (Fig. 3A and B): after 7 days of culture, we observed an
average of 11.8 104 5.1104 single cells/cm2 on the GGeGRGDS
gel surface whereas only 7.8  103  4.2  103 single cells/cm2 on
the GG surface. A similar trend was observed with encapsulated
cells. The number of single cells in the GGeGRGDS hydrogel of
8.1 104  2.3  104 single cells/cm2 was signiﬁcantly higher than
that in the GG hydrogel of 8.2 103 7.3 103. Interestingly, while
GRGDS modiﬁcation inﬂuenced the number of single cells present,
it did not affect the differentiation proﬁle, which was not signiﬁ-
cantly different (Fig. 3C). After 7 days, the majority of NSPCs on
GGeGRGDS and GG hydrogels were O4 positive oligodendrocytes
(72  11% and 64  30%, respectively) with relatively little differ-
entiation into astrocytes 7  12% vs. 0  0% and no differentiation
into neurons. Moreover, as judged by the nestin expression,
approximately one third of the NSPCs remained as progenitors
(32  16% vs. 36  19%).
3.3. Co-culture of OEG and NSPCs
The interaction of OEG and NSPCs was analyzed after 7 days in
culture for cell proliferation, and differentiation as a function of
direct contact or indirect contact (i.e. same media, but no contact
through use of a transwell). Interestingly, the differentiation proﬁle
of NSPCs was not altered by the presence of OEG (Fig. 4A); however,
NSPCs proliferated signiﬁcantly more when co-cultured with OEG
vs. alone. There was a 2.3 fold increase in the number of NSPCs
Fig. 1. Immobilization of the GRGDS peptide into the gellan gum hydrogel. (A) Schematic representation of the DielseAlder reaction (furanemaleimide conjugation) used for the GG
modiﬁcation. When DMT-MM and furfurylamine were incubated with the GG, a furan-modiﬁed gel with 27% substitution was synthesized. (B) 1H NMR spectrum of furaneGG. The
degree of substitution was calculated by comparing the ratio of the areas under the proton peaks at 6.26, 6.46 and 7.65 ppm (black arrows point to furan protons) to the peak at
1.2 ppm (white arrow point to methyl group of GG). (C) 1H NMR spectrum of GG, after incubation with furfurylamine in the absence of the coupling reagent DMT-MM. Furan peaks
were not detected in the GG spectrum (D) By reverse phase HPLC, the amino acid analyses revealed that when furaneGG and mal-GRGDS were incubated together it was possible to
obtain approximately 300 nmol GRGDS/mg of GG (gray arrows point to each amino acid). (E) In contrast, only 5.3 nmol of GRGDS peptide were detected in the control reaction
between maleimide-modiﬁed GRGDS and unmodiﬁed GG.
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(Fig. 4B) and a 1.8-fold increase in the number of NSPCs when co-
cultured indirectly in transwells with OEG vs. NSPC monocultures
(Fig. 4C). These results suggest that OEG secrete factors that
enhance NSPC proliferation and that the cells do not need to be in
contact in order for this affect to be observed. Unlike the prolifer-
ative effect that the OEG had on the NSPCs, the reverse was not
true: the total number of OEG was not signiﬁcantly affected by co-
culture with NSPCs either in direct contact (Fig. 4D) or indirect,
transwell (Fig. 4E) contact. Notwithstanding that OEG do not have
to be in direct contact with NSPCs to inﬂuence their proliferation,
immunocytochemistry illustrates that OEG are closely associated
with NSPCs when co-cultured together (Fig. 5). By pre-labeling OEG
green with CFSE34554 and counterstaining NSPCs with either
nestin (red for progenitors) or O4 (red for oligodendrocytes), the
two cell types appeared to be closely associated with each other.
These data suggest that OEG may be able to provide a guidance
pathway for NSPC growth.
3.4. Co-culture of OEG and NSPCs in the GGeGRGDS hydrogel
To gain greater insight into the interactions of OEG and NSPCs,
they were co-cultured together in the 3D gellan gum hydrogel
modiﬁed with the cell-adhesive peptide, GRGDS (GGeGRGDS). We
initially seeded 105 OEG and 4  104 NSPCs. Different cellular
densities were used because NSPCs have a higher proliferative ratethan OEG. After 7 days we estimated that both should be near
conﬂuence. To facilitate identiﬁcation, the OEG were pre-labeled
green with CFSE34554 and the NSPCs red with DDAO-SE 34553
prior to encapsulation in the GGeGRGDS hydrogel. As was
observed in the 2D co-culture study, the total number of NSPCs was
signiﬁcantly higher when co-cultured with OEG than when
cultured alone (Fig. 6A). Similar to the 2D data presented in Fig. 4,
the number of OEG was unaffected by the presence of NSPCs
(Fig. 6B).
4. Discussion
Gellan gum (GG) is a natural biomaterial that has shown
promise for tissue regeneration. It is a thermo-reversible gel that
was previously shown to be cytocompatible with adipose stem
cells, rabbit articular chondrocytes and immortalized oligoden-
drocytes [20,34]. Until recently, most of the research on GG modi-
ﬁcation was focused on controlling its mechanical properties
through gel network formation [21,35]. To the best of our knowl-
edge, there is no literature describing the chemical modiﬁcation of
GG with ECM-derived peptides, even though the cellular micro-
environment is deﬁned, in part, by its chemical nature. In order to
create a hydrogel which mimics the chemical nature of the ECM,
bioactive peptides were conjugated to GG, thereby providing
a more suitable environment for encapsulated cells to survive and
migrate.
Fig. 2. Morphology and dispersion of NSPCs on the GGeGRGDS. Confocal analyses revealed substantial differences in NSPC morphology when cultured either (A) on the surface or
(B) encapsulated within the GGeGRGDS vs. unmodiﬁed GG gel. Cell spreading and visible cytoplasmatic extensions were only observed in the GGeGRGDS. In the unmodiﬁed GG,
NSPCs proliferated as neurospheres. The cytoplasm was stained with the anti-F-actin/phalloidin (red) and nuclei counterstained with DAPI (blue). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 3. Bioactivity of the GGeGRGDS hydrogel. Proliferation analyses of NSPCs cultured either (A) on the surface of or (B) in the gel of the GGeGRGDS (black bars) vs. unmodiﬁed GG
(gray bars) showed that on the seventh day a signiﬁcantly higher number of single cells were found in the GGeGRGDS. Moreover, only in the GGeGRGDS was a signiﬁcant increase
in cell number observed from day 2 to day 7. (C) Immunocytochemistry revealed that the GRGDS sequence did not signiﬁcantly inﬂuence the differentiation proﬁle of the NSPCs.
Values are shown as mean  standard deviation (n ¼ 3 samples of 2  104 cells/sample, *p < 0.05; ***p < 0.001).
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peptide, which has been shown to enhance cellebiomaterial inter-
actions, support cell survival and inﬂuencecellmorphology [22,36]. In
thisworkweshowthat it ispossible to immobilize theGRGDSpeptide
to GG. By taking advantage of the DielseAlder click cycloaddition
reaction between chemically modiﬁed GGefuran and maleimide-
GRGDS, GGeGRGDS was synthesized in aqueous conditions.
Immobilization of GRGDS to GG had a profound effect on NSPC
morphology, distinct from that observed on NSPCs in unmodiﬁed
GG alone, demonstrating the importance of GRGDS for celleGG
interaction. Importantly, these morphological differences were
observed both within the 3D hydrogels and on their surfaces.
Unlike most studies that focus only on cells cultured on surfaces,
herein we cultured cells both on the hydrogel surface and encap-
sulated within [36,37]. Given that the ultimate goal involves cell
transplantation via an injectable hydrogel, it was reassuring that
the cell morphology in 3Dmirrored that in 2D. The NSPCswere able
to adhere to and extend processes within the GGeGRGDS hydrogel,
yet their differentiation proﬁle was not affected by the presence of
GRGDS. This reﬂects the cell-adhesive property ascribed to GRGDS
and not a differentiation property. To achieve preferential differ-
entiation to a given phenotype, GG would typically require further
modiﬁcation with growth factors, such as PDGF-AA for oligoden-
drocytes [38] or interferon-gamma for neurons [39].
The co-culture experiments of NSPCs and OEG, in direct contact
or in the transwell, suggested that diffusible factors are responsible
for the effects observed. OEG have been shown to secrete several
neurotrophic factors including: nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic
factor (GDNF) [13], basic ﬁbroblast growth factor (FGF2) and
neurotrophin-3 (NT-3) [40]. This rich proﬁle of secreted neuro-
trophins from OEG may explain the proliferation of NSPCs that we
observed in our co-culture studies. For example, NGF and FGF
promote NSPC proliferation [41,42]; and NT-3 enhances their
survival [43]. The combination of both mechanisms, survival and
proliferation, may explain the increased number of NSPCs in all of
the co-culture studies.
Other than this study, very little is known about the effects of
OEG on the behavior of NSPCs. Interestingly, Cao et al. [33], also
observed that OEG promoted NSPC proliferation, yet they also
observed increased neurogenesis and oligodendrogenesis of NSPCs
cultured with OEG. Differences in the co-culture experiments may
account for this discrepancy. Cao et al. harvested the NSPCs from
newborn mice, whereas we obtained NSPCs from adult rats;
moreover, they co-cultured the cells for only 3 days in DMEM with
F12 and N2 supplements whereas we co-cultured the cells for 7
days in neurobasal medium with B27 supplements.
The immunocytochemistry ﬁgures suggest that OEG and NSPCs
interact with each other. This interaction may be attributed to OEG
expressing cell-adhesive molecules, such as N-CAM and L1 [44],
and NSPCs expressing the corresponding receptors [45]. The
cellular interactions may suggest a role for co-transplantation of
OEG and NSPCs.
Cell transplantation has been pursued for several years for SCI
repair. Both OEG and NSPCs have been investigated independently,
each with some success. Notably, biomaterial scaffolds have been
N.A. Silva et al. / Biomaterials 33 (2012) 6345e6354 6351shown to enhance cell survival after transplantation. For example,
Cummings et al. [46] showed that transplanting human NSPCs in
SCI mice led to some locomotor recovery and remyelination.
Johnson et al. [47] demonstrated that implantation of ﬁbrin
hydrogels containing neural progenitor cells resulted in some
functional recovery in SCI rats. Ballios et al. demonstrated greaterFig. 4. OECs and NSPCs proliferation in transwells and direct contact co-culture. (A) The d
analysis showed that the total number of NSPCs is signiﬁcantly higher when in culture with O
cultures and in the (C) indirect transwell co-cultures. OECs proliferation was not signiﬁcant
transwell co-culture. Values are shown as mean  standard deviation (n ¼ 3 independentcell survival after transplantation in a hyaluronan/methylcellulose
hydrogel compared to saline [48]. OEG support and guide axon
elongation in their native olfactory system and have shown
promise after spinal cord injury as well [49,50]. OEG transplanted
immediately or up to 2 months after SCI in rats resulted in func-
tional recovery and/or tissue regeneration [51,52]. Signiﬁcantly,ifferentiation proﬁle of NSPCs was not affected by the presence of OECs. Proliferation
ECs than when cultured alone. This occurred both in the (B) direct cellecell contact co-
ly affected by the presence of NSPCs, either in (D) direct contact or in the (E) indirect
studies of a minimum of 4000 cells counted per study, *p < 0.05).
Fig. 6. Co-culture between OECs and NSPCs in the GGeGRGDS hydrogel. (A) After counting the cells, it was possible to observe that the number of NSPCs was signiﬁcantly higher
when co-cultured with OECs thanwhen cultured alone. (B) In contrast, OEC proliferationwas unaffected by the presence of NSPCs in culture. (C) Co-cultures of NSPCs (red, DDAO-SE
34553) and OECs (green, CFSE 34554) suggested some interaction between the two cell types as observed by confocal microscopy. (D) NSPCs and (E) OECs were cultured alone to
serve as controls. Values are shown as mean  standard deviation (n ¼ 3 independent experiments of 200 cells counted per experiment, *p < 0.05). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. OECs and NSPCs interact with each other during co-culture. (A) Monocultures of NSPCs and (B) Monocultures OECs served as controls. (C) OECs (green, CFSE 34554) and
NSPCs (red, O4) appear to be closely associated when the cells are cultured together in direct contact. NSPCs were identiﬁed by immunocytochemistry and nuclei are counterstained
with DAPI (blue). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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however, only very modest (if any) motor improvements were
observed. Despite the promise for cell therapy, with OEG or NSPCs,
the functional recovery has been modest, underlining the need for
innovative strategies, such as the combined transplantation of OEG
and NSPCs in a GGeGRGDS hydrogels. The simplicity and broad
applicability of the DielseAlder click chemistry can be easily
extended to other biomolecules to further promote NSPC differ-
entiation for greater integration with the host tissue. This combi-
nation strategy could be powerful, with OEG and gellan gum
providing a cellular pathway on which NSPCs could differentiate,
thereby replacing the damaged tissue and achieving greater func-
tional repair.
5. Conclusions
Using well-established DielseAlder click chemistry, we immobi-
lized the GRGDS ﬁbronectin-derived peptide to gellan gum hydro-
gels, which promoted greater adhesion and proliferation of neural
stem/progenitor cells than gellan gum controls. Moreover, NSPCs co-
culturedwith olfactoryensheathingglia showed greater survival and
outgrowth than NSPCs cultured alone. These results suggest that the
combined use of NSPCs and OEG with bioengineered GGeGRGDS
hydrogels may be beneﬁcial in regenerative medicine cell trans-
plantation strategies to promote repair after spinal cord injury.
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